Nikolay Boychev, Lisa Y Lin, Laurel T Tainsh, Sue A Aicher, Anat Galor, Joseph B Ciolino
{"title":"Cornea specialists are the highest opioid prescribers at a large academic eye institute in the USA.","authors":"Nikolay Boychev, Lisa Y Lin, Laurel T Tainsh, Sue A Aicher, Anat Galor, Joseph B Ciolino","doi":"10.1136/bmjophth-2024-002012","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aim: </strong>To evaluate the opioid prescription patterns across ophthalmic subspecialties at a large academic eye centre.</p><p><strong>Methods: </strong>A single site, retrospective cross-sectional study. Electronic medical records from the year 2018 were screened. Ophthalmology patients ≥18 years of age were included. The main outcome measures were patient demographics, outpatient opioid prescriptions, ophthalmic procedure and prescriber details, including department and training level.</p><p><strong>Results: </strong>1654 opioid prescriptions were written, accounting for 2.2% of all ophthalmic procedures in a calendar year. Of the patients who received prescriptions, 51.4% were female (n=851) with a mean age of 52.3±18.5 (range 18-95 years). In general, the morphine equivalent dose was low, with an average of 12.4±6.75 pills dispensed (range 1-60) with 0.0±0.01 refills (range 0-3). Cornea specialists were the highest opioid prescribers (22.7% of all providers who wrote a prescription), followed by oculoplastics (22.2%) and retina (18.4%). The most common procedure for which an opioid was prescribed was cornea crosslinking (14.3% of all opioid prescriptions).</p><p><strong>Conclusions: </strong>While opioid prescriptions are generally low for ophthalmic procedures across departments, cornea specialists accounted for nearly a third of opioid prescriptions. Over half of corneal crosslinking patients received opioid prescriptions; there remains an unmet need for opioid-sparing therapy for these patients and others with severe eye pain.</p>","PeriodicalId":9286,"journal":{"name":"BMJ Open Ophthalmology","volume":"10 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11877224/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Open Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjophth-2024-002012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background/aim: To evaluate the opioid prescription patterns across ophthalmic subspecialties at a large academic eye centre.
Methods: A single site, retrospective cross-sectional study. Electronic medical records from the year 2018 were screened. Ophthalmology patients ≥18 years of age were included. The main outcome measures were patient demographics, outpatient opioid prescriptions, ophthalmic procedure and prescriber details, including department and training level.
Results: 1654 opioid prescriptions were written, accounting for 2.2% of all ophthalmic procedures in a calendar year. Of the patients who received prescriptions, 51.4% were female (n=851) with a mean age of 52.3±18.5 (range 18-95 years). In general, the morphine equivalent dose was low, with an average of 12.4±6.75 pills dispensed (range 1-60) with 0.0±0.01 refills (range 0-3). Cornea specialists were the highest opioid prescribers (22.7% of all providers who wrote a prescription), followed by oculoplastics (22.2%) and retina (18.4%). The most common procedure for which an opioid was prescribed was cornea crosslinking (14.3% of all opioid prescriptions).
Conclusions: While opioid prescriptions are generally low for ophthalmic procedures across departments, cornea specialists accounted for nearly a third of opioid prescriptions. Over half of corneal crosslinking patients received opioid prescriptions; there remains an unmet need for opioid-sparing therapy for these patients and others with severe eye pain.